Overexpression of class III beta tubulin and amplified HER2 gene predict good response to paclitaxel and trastuzumab therapy.
about
HER2 expression beyond breast cancer: therapeutic implications for gynecologic malignanciesβIII-Tubulin: biomarker of taxane resistance or drug target?High levels of class III β-tubulin expression are associated with aggressive tumor features in breast cancer.Correlation of HER2, FCGR2A, and FCGR3A gene polymorphisms with trastuzumab related cardiac toxicity and efficacy in a subgroup of patients from UNICANCER-PACS 04 trial.Prevalence of βIII-tubulin (TUBB3) expression in human normal tissues and cancers.Esophageal cancer cells resistant to T-DM1 display alterations in cell adhesion and the prostaglandin pathway.
P2860
Overexpression of class III beta tubulin and amplified HER2 gene predict good response to paclitaxel and trastuzumab therapy.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Overexpression of class III be ...... taxel and trastuzumab therapy.
@ast
Overexpression of class III be ...... taxel and trastuzumab therapy.
@en
Overexpression of class III be ...... taxel and trastuzumab therapy.
@nl
type
label
Overexpression of class III be ...... taxel and trastuzumab therapy.
@ast
Overexpression of class III be ...... taxel and trastuzumab therapy.
@en
Overexpression of class III be ...... taxel and trastuzumab therapy.
@nl
prefLabel
Overexpression of class III be ...... taxel and trastuzumab therapy.
@ast
Overexpression of class III be ...... taxel and trastuzumab therapy.
@en
Overexpression of class III be ...... taxel and trastuzumab therapy.
@nl
P2093
P2860
P50
P1433
P1476
Overexpression of class III be ...... itaxel and trastuzumab therapy
@en
P2093
Byeong-Woo Park
Joo Hang Kim
Seung Il Kim
Soo Hyun Lee
Young Wha Moon
P2860
P304
P356
10.1371/JOURNAL.PONE.0045127
P407
P577
2012-09-20T00:00:00Z